Currently 1 in 13 people in the US are taking incretin-mimetic weight loss medications like Ozempic and Mounjaro. As practitioners, how much do we know about their impacts on our patients' oral health? Participants in this course will review the mechanisms of action and rationale for use of GLP-1-RA and GIPR medications. Attendees will also review the clinical implications for patients seeking dental care who are taking GLP-1-RA and GIPR medications.
Technology Recommendations
When viewing a pre-recorded course, we suggest the following:
Close all other applications and programs on your device.
Consider limiting the streaming on other devices in your viewing location.
Optimal viewing is on a computer or tablet.
A minimum 5MB connection is recommended, but please note that a 15-20MB connection is optimal.
The best way to prevent or stop buffering when streaming is to reduce anything that impedes the stream.
Date Available: 11/7/25
Date Reviewed: 3/1/26
Date Removed: 10/30/26